Exane Derivatives Medifast Inc Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Medifast Inc stock. As of the latest transaction made, Exane Derivatives holds 2 shares of MED stock, worth $36. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2
Previous 524
99.62%
Holding current value
$36
Previous $89,000
100.0%
% of portfolio
0.0%
Previous 0.03%
Shares
7 transactions
Others Institutions Holding MED
# of Institutions
164Shares Held
9.07MCall Options Held
520KPut Options Held
301K-
Jim Simons Renaissance Technologies LLC | New York, Ny1.01MShares$18.4 Million0.03% of portfolio
-
Black Rock Inc. New York, NY829KShares$15.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA726KShares$13.3 Million0.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT385KShares$7.04 Million0.01% of portfolio
-
Morgan Stanley New York, NY321KShares$5.87 Million0.0% of portfolio
About MEDIFAST INC
- Ticker MED
- Exchange NYSE
- Sector Consumer Cyclical
- Industry Personal Services
- Shares Outstandng 11,017,900
- Market Cap $202M
- Description
- Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft se...